• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    3/10/25 4:10:29 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care
    Get the next $LFMD alert in real time by email
    false 0000948320 0000948320 2025-03-10 2025-03-10 0000948320 LFMD:CommonStockParValue0.01PerShareMember 2025-03-10 2025-03-10 0000948320 LFMD:SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember 2025-03-10 2025-03-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): March 10, 2025

     

    LIFEMD, INC.

    (Exact name of Registrant as specified in its charter)

     

    Delaware   001-39785   76-0238453

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    236 Fifth Avenue, Suite 400

    New York, NY 10001

    (Address of principal executive offices, including zip code)

     

    (866) 351-5907

    (Registrant’s telephone number, including area code)

     

    Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

     

    ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.01 per share   LFMD   The Nasdaq Global Market
    Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share   LFMDP   The Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


     

     

     

    Item 2.02. Results of Operations and Financial Condition.

     

    On March 10, 2025, LifeMD, Inc. issued a press release announcing its financial results for the three months and year ended December 31, 2024, and its earnings guidance for 2025. A copy of the press release is furnished herewith as Exhibit 99.1.

     

    The information in this Item 2.02 (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.

     

    Item 9.01. Exhibits.

     

    (d) Exhibits

     

    Exhibit No.   Exhibit
    99.1   Press Release dated March 10, 2025
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        LIFEMD, INC.
           
    Dated: March 10, 2025 By: /s/ Marc Benathen
          Marc Benathen
          Chief Financial Officer

     

     

    Get the next $LFMD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $LFMD

    DatePrice TargetRatingAnalyst
    6/18/2025$15.00 → $18.00Buy
    BTIG Research
    12/10/2024$12.00Buy
    Lake Street
    12/4/2024$7.00Neutral
    Mizuho
    8/23/2024$11.00Buy
    B. Riley Securities
    6/5/2024$12.00Overweight
    KeyBanc Capital Markets
    11/30/2023$10.00Buy
    Craig Hallum
    7/21/2023$7.00Overweight
    Cantor Fitzgerald
    7/3/2023$9.00Buy
    H.C. Wainwright
    More analyst ratings

    $LFMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research reiterated coverage on LifeMD with a new price target

      BTIG Research reiterated coverage of LifeMD with a rating of Buy and set a new price target of $18.00 from $15.00 previously

      6/18/25 10:55:14 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Lake Street initiated coverage on LifeMD with a new price target

      Lake Street initiated coverage of LifeMD with a rating of Buy and set a new price target of $12.00

      12/10/24 8:29:49 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Mizuho initiated coverage on LifeMD with a new price target

      Mizuho initiated coverage of LifeMD with a rating of Neutral and set a new price target of $7.00

      12/4/24 7:42:36 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

      NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2025, to holders of record at the close of business on July 3, 2025. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's heal

      6/23/25 4:05:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD to Participate in Two Investor Conferences During June

      NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity Health Forum, June 18. Management will participate in a virtual panel discussion titled "Direct to Consumer vs. Direct to Enterprise" at 2:00 p.m. Eastern time. Institutional investors can register for the conference by contacting their BTIG representative or by clicking here. Truist Securities Healthcare Disruptors & Digital Health Conference, June 24-25 at the Park Lane Hotel in New York City. Management will participate in a panel dis

      6/9/25 8:00:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

      NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes both the medication and access to LifeMD's virtual weight management program. As part of its collaboration with Novo Nordisk announced last month, LifeMD is offering Wegovy® at a discounted price of $199 for eligible patients through its recently completed integration with NovoCare® Pharmacy, with an additional $100 covering LifeMD's clinical care, onboarding, and ongoing support. The collaboration with Novo Nordisk strengthens LifeMD's a

      5/22/25 8:05:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    SEC Filings

    See more
    • LifeMD Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - LifeMD, Inc. (0000948320) (Filer)

      6/16/25 4:43:54 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by LifeMD Inc.

      10-Q - LifeMD, Inc. (0000948320) (Filer)

      5/6/25 4:45:42 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - LifeMD, Inc. (0000948320) (Filer)

      5/6/25 4:10:25 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Innovation Officer Galluppi Stefan bought $14,790 worth of shares (3,000 units at $4.93), increasing direct ownership by 7% to 45,449 units (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      9/12/24 2:10:03 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman and CEO Schreiber Justin sold $334,458 worth of shares (25,000 units at $13.38) (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      7/3/25 3:53:16 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Chief Financial Officer Benathen Marc David sold $1,682,440 worth of shares (125,000 units at $13.46), decreasing direct ownership by 27% to 339,554 units (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      6/18/25 6:18:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer & GC Yecies Eric Harold sold $183,750 worth of shares (15,000 units at $12.25) (SEC Form 4)

      4 - LifeMD, Inc. (0000948320) (Issuer)

      6/17/25 6:12:19 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by LifeMD Inc.

      SC 13G/A - LifeMD, Inc. (0000948320) (Subject)

      11/14/24 10:42:44 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by LifeMD Inc. (Amendment)

      SC 13G/A - LifeMD, Inc. (0000948320) (Subject)

      2/14/24 3:33:22 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by LifeMD Inc.

      SC 13G - LifeMD, Inc. (0000948320) (Subject)

      10/6/23 5:26:16 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care

    $LFMD
    Leadership Updates

    Live Leadership Updates

    See more
    • LifeMD Set to Join the Russell 3000 Index

      NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1st, according to a preliminary list of additions posted Friday, May 24th. The annual Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks as of Tuesday, April 30th, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Ind

      5/29/24 8:00:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Appoints Dr. Calum MacRae to its Board of Directors

      NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors. "We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management and the implementation of novel solutions to improve the delivery of virtual healthcare services," said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. "Aside from being a world-reno

      4/29/24 8:00:00 AM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • LifeMD Appoints William J. Febbo to its Board of Directors

      NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of William (Will) J. Febbo, Chief Executive Officer and Director of OptimizeRx Corporation (NASDAQ:OPRX) to its Board of Directors. OptimizeRx is a leading provider of digital point-of-care technology solutions that help patients start and stay on therapy. "We are extremely pleased to welcome Will to our Board. He brings to LifeMD a depth of experience in building and managing healthcare companies, and pioneering technology to improve the experience for healthcare providers and patients," said Justin Schreiber, Chairman and Chief Exec

      6/20/23 8:00:00 AM ET
      $LFMD
      $OPRX
      Medical/Nursing Services
      Health Care
      Business Services
      Consumer Discretionary

    $LFMD
    Financials

    Live finance-specific insights

    See more
    • LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

      NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2025, to holders of record at the close of business on July 3, 2025. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's heal

      6/23/25 4:05:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care
    • Medifast Announces First Quarter 2025 Financial Results

      Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (NASDAQ:LFMD) common stock of $0.4 million (net of tax) Loss per share of $0.07 Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt "In today's health and wellness landscape, more people than ever are seeking guidance not just for we

      4/28/25 4:05:00 PM ET
      $LFMD
      $MED
      Medical/Nursing Services
      Health Care
      Packaged Foods
      Consumer Staples
    • LifeMD to Report First Quarter 2025 Financial Results on May 6

      NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Tuesday, May 6thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-225-9448International Dial-In:203-518-9708Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, a

      4/28/25 4:05:00 PM ET
      $LFMD
      Medical/Nursing Services
      Health Care